CTLA4 and glioblastoma: Although there has been no published data on CTLA-4 inhibitors solely treating GBM yet, some clinical trials are currently ongoing to evaluate CTLA-4 inhibitors in GBM combined with other therapeutic agents, such as VEGF inhibitors, checkpoint inhibitors, tumor treating fields, and radiation therapy (73).